Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0000899243-21-020862

Options or other derivatives

  • Director acquired 22,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Vera Juan · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-05-25 Grant or award : show line 1 in the form Stock Option (Right to Buy) +22,500 $21.51 2031-05-24 22,500 22,500 D
Loading xslF345X03/doc4.xml…